Skip to main content
NRKNuveen New York AMT-Free QualitHold5.3·$9.52
HoldModerate Confidence
Investment thesis

This is a high-quality, attractively valued holding with positive momentum, but weak growth and a stretched position near its 52-week high leave near-term risk/reward geometry unattractive.

Thesis pillars

  • High Quality Strong Margins→Stable
  • Attractive Valuation Low Peg→Stable
  • Declining Revenue Growth Concern→Stable
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Jul 5, 2026

Full reasoning →

Open full analysis

Nuveen New York AMT-Free Qualit (NRK) Stock Analysis

Recovery setup · Temporary headwind edge

HoldValueGrowthQualityShortModerate Confidence

Financial Services · Asset Management

Hold if already holding. Not a fresh buy at $9.52, but acceptable to hold if already in. Reasons: Weak growth; Negative momentum.

Nuveen New York AMT-Free Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New York. The... Read more

$9.52+15.0% A.UpsideScore 5.3/10#153 of 229 Asset Management
QualityF-score8 / 9FCF yield—
IncomeYield8.26%(5y avg 5.62%)Payout258.75%at-risk
Stop $9.20Default target $10.95A.R:R 0.0:1

Hold if already holding. Not a fresh buy at $9.52, but acceptable to hold if already in. Reasons: Weak growth; Negative momentum. Chart setup: Death cross but MACD improving, RSI 65. Maintain position. Not compelling to add more. Score 5.3/10, moderate confidence.

Passes 6/9 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.

Thesis

Rewards
V7 flight-to-quality bonus: +0.5 (Q=8.6 in RISK_OFF)
Sector modifier (Financial Services): +1.0
High-quality business
Risks
Weak growth
Negative momentum
Below 200-day MA

Key Metrics

P/E (TTM)29.8
P/E (Fwd)—
Mkt Cap$830M
EV/EBITDA—
Profit Mgn35.7%
ROE—
Rev Growth-1.8%
Beta0.66
Dividend8.26%
Rating analysts—

Quality Signals

Piotroski F8/9MoatNarrow

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

4 floor-breakers·2 ceiling hits

Revenue shrinking — -1.8% YoY. Growth thesis broken unless recovery story develops.static

Revenue Growth
2.0
Declining revenue: -2%
Low model confidence on this dimension (33%).

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
1.1
52w Position
7.7

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Obv
1.0
Volume
2.1
Rsi
3.5
Ma Position
4.5
Macd
7.2
Volume distribution (falling OBV)Below 200-MA, MA slope flat

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
2.7
Growth Rank
3.5
Quality Rank
5.4
GatesMomentum 3.7<4.5Death cross (50MA < 200MA)A.R:R UPSIDE_EXHAUSTED (upside=0.0%)Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
65 · Neutral
↑ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $8.97Resistance $9.59

Price Targets

$9
$11
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! momentum at 3.7 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

We could not retrieve earnings history for NRK.
The company may be recently listed, pre-revenue, or its beat/miss record wasn't available from our source this run. Earnings signals feed the Growth and Catalyst score dimensions — absence here doesn't affect other dimensions.

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is NRK stock a buy right now?

Hold if already holding. Not a fresh buy at $9.52, but acceptable to hold if already in. Reasons: Weak growth; Negative momentum. Chart setup: Death cross but MACD improving, RSI 65. Maintain position. Not compelling to add more. Default target $10.95 (+15.0%), stop $9.20 (−3.5%), A.R:R 0.0:1. Score 5.3/10, moderate confidence.

What is the NRK stock price target?

Default target: $10.95 (+15.0% upside). Default target $10.95 (+15.0%), stop $9.20 (−3.5%), A.R:R 0.0:1. Stop-loss: $9.20.

What are the risks of investing in NRK?

Weak growth; Negative momentum; Below 200-day MA.

Is NRK overvalued or undervalued?

Nuveen New York AMT-Free Qualit trades at a P/E of 29.8 (forward N/A). TrendMatrix value score: 7.4/10. Verdict: Hold.

0
What does Nuveen New York AMT-Free Qualit do?Nuveen New York AMT-Free Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen...

Nuveen New York AMT-Free Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New York. The fund invests in undervalued municipal securities and other related investments the income, covered by insurance from insurers with a claims-paying ability, exempt from regular federal and New York income tax and are rated Baa, BBB or better and having an average maturity of 15.98 years. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's (S&P) New York Municipal Bond Index and the Standard & Poor's (S&P) Insured National Municipal Bond Index. It was formerly known as Nuveen New York AMT-Free Municipal Income Fund. Nuveen New York AMT-Free Quality Municipal Income Fund was formed on July 29, 2002 and is domiciled in the United States.

Related stocks: GAB (Gabelli Equity Trust, Inc. (The) · HLNE (Hamilton Lane Incorporated) · CII (BlackRock Enhanced Large Cap Co) · TWN (Taiwan Fund, Inc. (The)) · FFA (First Trust Enhanced Equity Inc)
Home › Stocks › NRK

Latest news

No recent news